Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to isomalto-oligosaccharides and reduction of post-prandial glycaemic responses, and increase in the frequency of daily bowel movements. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is isomalto-oligosaccharides. The Panel considers that isomalto-oligosaccharides is sufficiently characterised
Scientific Opinion on the substantiation of health claims related to isomalto-oligosaccharides and reduction of post-prandial glycaemic responses (ID 798), and increase in the frequency of daily bowel movements (ID 800) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 / E. Panel on Dietetic Products, N. Allergies, E. Panel on Dietetic Products, N. Allergies, C.V. Agostoni, J.L. Bresson, S. Fairweather Tait, A. Flynn, I. Golly, H. Korhonen, P. Lagiou, M. Løvik, R. Marchelli, A. Martin, B. Moseley, M. Neuhäuser Berthold, H. Przyrembel, S. Salminen, Y. Sanz, S. Strain, S. Strobel, I. Tetens, D. Tomé, H. van Loveren, H. Verhagen. - In: EFSA JOURNAL. - ISSN 1831-4732. - 8:10(2010), pp. 1-14. [10.2903/j.efsa.2010.1801]
Scientific Opinion on the substantiation of health claims related to isomalto-oligosaccharides and reduction of post-prandial glycaemic responses (ID 798), and increase in the frequency of daily bowel movements (ID 800) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
C.V. Agostoni;
2010
Abstract
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to isomalto-oligosaccharides and reduction of post-prandial glycaemic responses, and increase in the frequency of daily bowel movements. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is isomalto-oligosaccharides. The Panel considers that isomalto-oligosaccharides is sufficiently characterisedPubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.